LSL Pharma Group Inc. (TSXV:LSL)

Revenue by Segment

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Oct 3, 2020
Vitamins & Nutrition Products	17.75M	10.03M	8.21M	8.77M	10.05M
Vitamins & Nutrition Products Growth	76.98%	22.08%	-6.35%	-12.70%	108.32%
Total	17.75M	10.03M	8.21M	8.77M	10.05M
Total Growth	76.98%	22.08%	-6.35%	-12.70%	108.32%

Revenue by Geography

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Oct 3, 2020
Canada	17.75M	10.03M	8.21M	8.77M	10.05M
Canada Growth	76.98%	22.08%	-6.35%	-12.70%	108.32%
Total	17.75M	10.03M	8.21M	8.77M	10.05M
Total Growth	76.98%	22.08%	-6.35%	-12.70%	108.32%

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 30, 2026

Data Sources Report a data error